Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Showing results for "1"

Research

Early analysis of the Australian Covid-19 epidemic

As of 1 May 2020, there had been 6808 confirmed cases of COVID-19 in Australia. Of these, 98 had died from the disease. The epidemic had been in decline since mid-March, with 308 cases confirmed nationally since 14 April.

Research

Factors Associated with Respiratory Illness in Children and Young Adults with Cerebral Palsy

Oromotor dysfunction is strongly associated with respiratory illness in patients with cerebral palsy

Theme Leads

Read about the Research Focus Area Leads at the Children's Diabetes Centre.

News & Events

Self-efficacy groups 2020

Perth Children’s Hospital’s Diabetes Service has released the dates for its self-efficacy groups for 2020.

News & Events

Diabete$ Re$earch in Au$tralia

It may surprise you to know that the Australian government has invested almost $300 million dollars since 2000 towards research and clinical trials for diabetes

Sibling Support

At CliniKids, we offer group or individual support for siblings of autistic children.

Research

Glycemic and Psychosocial Outcomes of Advanced Hybrid Closed-Loop Therapy in Youth With High HbA1c: A Randomized Clinical Trial

To determine the efficacy of advanced hybrid closed-loop therapy in a high-risk cohort of youth on continuous subcutaneous insulin infusion with or without continuous glucose monitoring with suboptimal glycemia.

Research

Piloting a self-compassion program to promote physical and psychological wellbeing in youth with T1D

Amy Keely Liz Asha Finlay-Jones Bebbington Davis Parkinson BPsych(Hons), MPsych(Clinical), MHealthEcon, PhD (Clin Psych) MClinPsych/PhD MBBS FRACP

Research

Study of tranexamic acid on post-tonsillectomy haemorrhage (STOP) pilot trial

Matt Cooper BCA Marketing, BSc Statistics and Applied Statistics, PhD Manager, Biostatistics 08 6319 1723 matt.cooper@thekids.org.au Manager,

Research

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia

We report vaccine efficacy against CIN3+ and adenocarcinoma in situ (AIS) in the end-of-study analysis of PApilloma TRIal against Cancer In young Adults.